Results 61 to 70 of about 18,898 (135)

Incidence of Barrett's esophagus and esophageal cancer following sleeve gastrectomy versus liraglutide therapy. [PDF]

Ann Gastroenterol
Butt E, Yang J.
europepmc   +1 more source

The Effect of Liraglutide on the Hypolipidemic, Anti-Inflammatory, and Antioxidant Properties of Atorvastatin Mediated via the Nrf2/HO-1 Signaling Pathway: In Vivo and In Silico Validation. [PDF]

Pharmaceutics
Kamar SA, Magdy YM, Abuamara TMM, Sedky AA, Al-Hazani TMI, Alhelf M, Zayed ES, A Yousef T, Al-Dakhil A, Abou-Krisha MM, Almehmadi SJ, Khedr S.   +11 more
europepmc   +1 more source

Potential of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Mitigating Metabolic Side Effects Associated With Clozapine or Olanzapine Therapy: A Literature Review. [PDF]

Cureus
Meftah A, Yoade B, Cowart C, Choi A, Popoola O, Afe O, Efremoff S, Ezema C, Johnson B, Lawrence J, Olupona T.   +10 more
europepmc   +1 more source

Hypoglycemia Reporting in GLP-1RA Trials for Type 1 Diabetes: A Critical Gap That Needs To Be Addressed. [PDF]

Endocrinol Diabetes Metab
Ishtiaq S, Malik ZM, Ahmad AR.
europepmc   +1 more source

Correction to "Aggregation-driven expression of liraglutide precursors using engineered mini-tags in Escherichia coli". [PDF]

Protein Sci
europepmc   +1 more source

The Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-Transporter-2 Inhibitors on Lean Body Mass in Humans: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. [PDF]

Diabetes Metab Res Rev
Jobanputra R, Sargeant JA, Plekhanova T, James E, Almaqhawi A, Webb DR, Davies MJ, Yates T.   +7 more
europepmc   +1 more source

Liraglutide Modifies Gut Microbiota Without Modulating Doxorubicin-Induced Toxicity in Rats. [PDF]

Antioxidants (Basel)
Tonon CR, Monte MG, Ballin PS, Fujimori ASS, Ferreira NF, Vieira NM, Carreira LP, Rodrigues MAM, Rodrigues J, Almeida Junior L, Di Stasi LC, Santos A, Magro DO, Minicucci MF, Zornoff LAM, Okoshi MP, Paiva SAR, Polegato BF.   +17 more
europepmc   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists: Their Potential Role in Prediabetes. [PDF]

Diabetes Ther
Panou T, Gouveri E, Popovic DS, Papazoglou D, Papanas N.   +4 more
europepmc   +1 more source

Liraglutide and Dapagliflozin Synergistically Reshape Gut Microbiota and Metabolic Profiles to Ameliorate Type‑2 Diabetes in Mice. [PDF]

ACS Omega
Tan AJ, Li TR, Yang JJ, Li XL, Li WQ, Yu JW.   +5 more
europepmc   +1 more source

GLP-1 Agonists in Orthopedic Surgery: A Narrative Review of Bone Health and Surgical Implications. [PDF]

HSS J
Restrepo Mejia M, Tiao J, Yu A, Baidya J, Rajjoub M, Busigo Torres R, Chaudhary SB.   +6 more
europepmc   +1 more source